A short-scan method for k 3 estimation with moderately reversible PET ligands: Application of irreversible model to early-phase PET data

NeuroImage

Volumn 59, Issue 4, 2012, Pages 3149-3158

  Sato, Koichi ^a,b   Fukushi, Kiyoshi ^a   Shinotoh, Hitoshi ^a,c   Shimada, Hitoshi ^a   Tanaka, Noriko ^a,d   Hirano, Shigeki ^a,e   Irie, Toshiaki ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b TEIKYO UNIVERSITY CHIBA MEDICAL CENTER   (Japan)

^c Asahi Hospital for Neurological Diseases and Rehabilitation   (Japan)

^d TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^e CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

11C PIB; Compartment models; Information density; PET; Reversible ligand; Tracer kinetics

Indexed keywords

CARBON 11; LIGAND;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EQUILIBRIUM CONSTANT; HUMAN; HUMAN TISSUE; KINETICS; MATHEMATICAL ANALYSIS; MONTE CARLO METHOD; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SIMULATION;

AGED; AGED, 80 AND OVER; BENZOTHIAZOLES; BRAIN; CARBON RADIOISOTOPES; HUMANS; LIGANDS; MIDDLE AGED; MODELS, BIOLOGICAL; POSITRON-EMISSION TOMOGRAPHY;

EID: 84855163191     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2011.10.087     Document Type: Article

References (32)

1. Blomquist G., Englar H., Nordberg A., Ringheim A., Wall A., Forsberg A., Estrada M., Franberg P., Antoni G., Langstrom B. Unidirectional influx and net accumulation of PIB. Open Neuroimaging J. 2008, 2:114-125.
2. Carson R.E. Parameter estimation on PET. Positron Emission Tomography and Autoradiography: Principle and Application for the Brain and Heart 1986, 347-390. Raven Press, New York, NY. M.E. Phelps, J.C. Mazziotta, H.R. Schelbert (Eds.).
3. 11C]PIB with plasma input functions considering discriminations and reproducibility. NeuroImage 2009, 48:329-338.
4. 11C]raclopride displacement studies: understanding the true mechanism. Mol. Imaging Biol. 2005, 7:45-52.
5. Gunn R.N., Gunn S.R., Cunningham V.J. Positron emission tomography compartmental models. J. Cereb. Blood Flow Metab. 2001, 21:635-652.
6. Hume S.P., Myers R., Bloomfield P.M., Opacka-Juffry J., Cremer J.E., Ahier R.G., Luthra S.K., Brooks D.J., Lammertsma A.A. Quantification of carbon-11-labeled raclopride in rat striatum using positron emission tomography. Synapse 1992, 12:47-54.
7. Ichise M., Ballinger J.R., Golan H., Vines D., Luong A., Tsai S., Kung H.F. Noninvasive quantification of dopamine D2 receptors with iodine-123-IBF SPECT. J. Nucl. Med. 1996, 37:513-520.
8. Innis R.B., Cunningham V.J., Delforge J., Fujita M., Gjedde A., Gunn R.N., Holden J., Houle S., Huang S.C., Ichise M., Iida H., Ito H., Kimura Y., Koeppe R.A., Knudsen G.M., Knuuti J., Lammertsma A.A., Laruelle M., Logan J., Maguire R.P., Mintun M.A., Morris E.D., Parsey R., Price J.C., Slifstein M., Sossi V., Suhara T., Votaw J.R., Wong D.F., Carson R.E. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J. Cereb. Blood Flow Metab. 2007, 27:1533-1539.
9. Irie T., Fukushi K., Akimoto Y., Tamagami H., Nozaki T. Design and evaluation of radioactive acetylcholine analogs for mapping brain acetylcholinesterase (AchE) in vivo. Nucl. Med. Biol. 1994, 21:801-808.
10. Kilbourn M.R., Nguyen T.B., Snyder S.E., Koeppe R.A. One for all, or one for each? Matching radiotracers and regional brain pharmacokinetics. Quantitative Functional Brain Imaging with Positron Emission Tomography 1998, 261-265. Academic Press, San Diego, CA, (BRAINPET97, proceedings). R.E. Carson, M.E. Daube-Witherspoon, P. Herscovitch (Eds.).
11. 11C]methylpiperidin-4-yl propionate: alternatives for analysis of an irreversible positron emission tomography tracer for measurement of acetylcholinesterase activity in human brain. J. Cereb. Blood Flow Metab. 1999, 19:1150-1163.
12. Lammertsma A.A., Hume S.P. Simplified reference tissue model for PET receptor studies. NeuroImage 1996, 4:153-158.
13. 11C]raclopride studies. J. Cereb. Blood Flow Metab. 1996, 16:42-52.
14. Laruelle M. Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J. Cereb. Blood Flow Metab. 2000, 20:423-451.
15. Logan J. Graphical analysis of PET data applied to reversible and irreversible tracers. Nucl. Med. Biol. 2000, 27:661-670.
16. 11C-methyl]-(-)-cocaine PET studies in human subjects. J. Cereb. Blood Flow Metab. 1990, 10:740-747.
17. Logan J., Fowler J.S., Volkow N.D., Ding Y.S., Wang G.J., Alexoff D.L. A strategy for removing the bias in the graphical analysis method. J. Cereb. Blood Flow Metab. 2001, 21:307-320.
18. Lopresti B.J., Klunk W.E., Mathis C.A., Hoge J.A., Ziolko S.K., Lu X., Meltzer C.C., Schimmel K., Tsopelas N.D., DeKosky S.T., Price J.C. Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis. J. Nucl. Med. 2005, 46:1959-1972.
19. 11C-labeled 6-substituted 2-aryl benzothiazoles as amyloid imaging agents. J. Med. Chem. 2003, 46:2740-2754.
20. Mazoyer B.M., Huesman R.H., Budinger T.F., Knittel B.L. Dynamic PET data analysis. J. Comput. Assist. Tomogr. 1986, 10:645-653.
21. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
22. Mintun M.A., Raichle M.E., Kilbourn M.R., Wooten G.F., Welch M.J. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann. Neurol. 1984, 15:217-227.
23. Morris E.D., Yoder K.K. Positron emission tomography displacement sensitivity: predicting binding potential change for positron emission tomography tracers based on their kinetic characteristics. J. Cereb. Blood Flow Metab. 2007, 27:606-617.
24. 11C]MP4A using a high-radioactivity brain region that represents an integrated input function for measurement of cerebral acetylcholinesterase activity without arterial blood sampling. J. Cereb. Blood Flow Metab. 2001, 21:1354-1366.
25. Namba H., Iyo M., Fukushi K., Shinotoh H., Nagatsuka S., Suhara T., Sudo Y., Suzuki K., Irie T. Human cerebral acetylcholinesterase activity measured with positron emission tomography: procedure, normal values and effect of age. Eur. J. Nucl. Med. 1999, 26:135-143.
26. Price J.C., Klunk W.E., Lopresti B.J., Lu X., Hoge J.A., Ziolko S.K., Holt D.P., Meltzer C.C., DeKosky S.T., Mathis C.A. Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. J. Cereb. Blood Flow Metab. 2005, 25:1528-1547.
27. 11C]methylpiperidine-4-yl propionate and positron emission tomography. J. Cereb. Blood Flow Metab. 2004, 24:600-611.
28. 18F]fluorodeoxyglucose method. J. Cereb. Blood Flow Metab. 1992, 12:823-834.
29. Shimada H., Hirano S., Shinotoh H., Aotsuka A., Sato K., Tanaka N., Ota T., Asahina M., Fukushi K., Kuwabara S., Hattori T., Suhara T., Irie T. Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET. Neurology 2009, 73:273-278.
30. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem. 1977, 28:897-916.
31. Wong D.F., Gjedde A., Wagner H.N. Quantification of neuroreceptors in the living human brain, I. Irreversible binding of ligands. J. Cereb. Blood Flow Metab. 1986, 6:137-146.
32. Wu Y., Carson R.E. Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging. J. Cereb. Blood Flow Metab. 2002, 22:1440-1452.